PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Purified anti-β-Actin, 50 μl
Ultra-LEAF™ Purified anti-Activin A, 1 mg
Ultra-LEAF™ Purified anti-Activin A, 100 μg
Ultra-LEAF™ Purified anti-CCL11, 500 μg
Ultra-LEAF™ Purified anti-CCL15, 1 mg
Ultra-LEAF™ Purified anti-CCL15, 100 μg
Ultra-LEAF™ Purified anti-human CCL22, 1 mg
Ultra-LEAF™ Purified anti-human CCL22, 100 μg
Ultra-LEAF™ Purified anti-human CRP (C-reactive protein), 1 mg
Ultra-LEAF™ Purified anti-human CRP (C-reactive protein), 100 μg
Ultra-LEAF™ Purified anti-human IGFBP-4, 1 mg
Ultra-LEAF™ Purified anti-human IGFBP-4, 100 μg
Ultra-LEAF™ Purified anti-human IL-11, 1 mg
Ultra-LEAF™ Purified anti-human IL-11, 100 μg
Ultra-LEAF™ Purified anti-human IL-3, 1 mg
Ultra-LEAF™ Purified anti-human IL-3, 100 μg